CD44 and gastric cancer: The investigators tested the synthesized GNS-PEG-CD44v6 (taken as the test group) to selectively eliminate gastric cancer stem cells (GCSCs), for which the CD44+-expressing spheroid colonies were incubated with the test group and GNS-PEG (taken as the control group), along with untreated GCSCs for comparison.